| Supplier: | Boster |
|---|---|
| Reference: | A02179-1 |
| Name: | Anti-CIKS (Act1) TRAF3IP2 Antibody |
| Category: | Antibody |
| Subcategory: | Primary Antibodies |
| Research Area: | Domain Families,Epigenetics and Nuclear Signaling,Hlh/Leucine Zipper,NFKB Pathway,Nuclear Signaling Pathways,Signal Transduction,Signaling Pathway,Transcription |
| Unit: | 100ug |
| Concentration: | 0.5-1mg/ml, actual concentration vary by lot. Use suggested dilution ratio to decide dilution procedure. |
| Clonality: | Polyclonal |
| Price: | Consultar |
| Format: | Liquid. In PBS containing 0.02% sodium azide. |
| Immunogen: | Synthetic peptide corresponding to the sequence near |
| Host: | Rabbit |
| Reactivity: | Human |
| Application: | IHC,WB |
| Description: | Boster Bio Anti-CIKS (Act1) TRAF3IP2 Antibody catalog # A02179-1. Tested in IHC, WB applications. This antibody reacts with Human. |
| Purification: | Peptide affinity purified. |
| Storage conditions: | +4°C |
| Assay inforation: | Immunohistochemistry (5µg/ml) Western Blot (0.5-1.0µg/ml) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |